Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors-Reference-Cited by-同舟云学术

Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors

Published:2000-11 Issue:2 Volume:88 Page:115-131
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Pyne Susan,Pyne Nigel

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference123 articles.

1. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase;Alemany;J Biol Chem,1999

2. Transduction of intracellular calcium signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors;An;Mol Pharmacol,1999

3. Signalling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate;An;J Cell Biochem,1998

4. Sphingosine 1-phosphate-induced cell proliferation, survival and related events mediated by G protein-coupled receptors EDG3 and EDG5;An;J Biol Chem,2000

5. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG1, EDG3, and EDG5;Ancellin;J Biol Chem,1999

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer;International Journal of Molecular Sciences;2024-03-15

2. The glucocorticoid response element near the sphingosine-1-phopshate receptor 3 gene mitigates inflammatory processes and maladaptive behavior in females and stressed males;2024-01-11

3. Lymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets;Signal Transduction and Targeted Therapy;2024-01-03

4. Sphingosine-1-Phosphate Receptor 3 Induces Endothelial Barrier Loss via ADAM10-Mediated Vascular Endothelial-Cadherin Cleavage;International Journal of Molecular Sciences;2023-11-08

5. Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets;Frontiers in Oncology;2022-06-08